Global costs, health benefits, and economic benefits of scaling up treatment and imaging modalities for survival of 11 cancers: a simulation-based analysis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Global costs, health benefits, and economic benefits of scaling up treatment and imaging modalities for survival of 11 cancers: a simulation-based analysis
Authors
Keywords
-
Journal
LANCET ONCOLOGY
Volume 22, Issue 3, Pages 341-350
Publisher
Elsevier BV
Online
2021-03-02
DOI
10.1016/s1470-2045(20)30750-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries
- (2020) Karen Canfell et al. LANCET
- Sustainable care for children with cancer: a Lancet Oncology Commission
- (2020) Rifat Atun et al. LANCET ONCOLOGY
- Estimating the impact of treatment and imaging modalities on 5-year net survival of 11 cancers in 200 countries: a simulation-based analysis
- (2020) Zachary J Ward et al. LANCET ONCOLOGY
- The role and contribution of treatment and imaging modalities in global cervical cancer management: survival estimates from a simulation-based analysis
- (2020) Zachary J Ward et al. LANCET ONCOLOGY
- Incidence and death in 29 cancer groups in 2017 and trend analysis from 1990 to 2017 from the Global Burden of Disease Study
- (2019) Longfei Lin et al. Journal of Hematology & Oncology
- Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
- (2018) Claudia Allemani et al. LANCET
- Bringing down the cost of cancer treatment
- (2018) Elie Dolgin NATURE
- 20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
- (2017) Hongchao Pan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evidence-based indications for the use of PET-CT in the United Kingdom 2016
- (2016) The Royal College of Radiologists et al. CLINICAL RADIOLOGY
- PEPFAR Investments In Governance And Health Systems Were One-Fifth Of Countries’ Budgeted Funds, 2004–14
- (2016) Corrina Moucheraud et al. HEALTH AFFAIRS
- Expanding global access to radiotherapy
- (2015) Rifat Atun et al. LANCET ONCOLOGY
- Global health 2035: a world converging within a generation
- (2013) Dean T Jamison et al. LANCET
- Global cancer transitions according to the Human Development Index (2008–2030): a population-based study
- (2012) Freddie Bray et al. LANCET ONCOLOGY
- Expansion of cancer care and control in countries of low and middle income: a call to action
- (2010) Paul Farmer et al. LANCET
- Cost Effectiveness in Low- and Middle-Income Countries
- (2009) Samuel D. Shillcutt et al. PHARMACOECONOMICS
- Impact of Positron Emission Tomography/Computed Tomography and Positron Emission Tomography (PET) Alone on Expected Management of Patients With Cancer: Initial Results From the National Oncologic PET Registry
- (2008) Bruce E. Hillner et al. JOURNAL OF CLINICAL ONCOLOGY
- PET Changes Management and Improves Prognostic Stratification in Patients with Recurrent Colorectal Cancer: Results of a Multicenter Prospective Study
- (2008) A. M. Scott et al. JOURNAL OF NUCLEAR MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started